The inhibitory effects of alphaxalone on M1 and M3 muscarinic receptors expressed in Xenopus oocytes

Anesthesia and Analgesia

Volumn 97, Issue 2, 2003, Pages 449-455

  Shiraishi, Munehiro ^a   Minami, Kouichiro ^a   Shibuya, Izumi ^a   Uezono, Yasuhito ^b   Ogata, Junichi ^a   Okamoto, Takashi ^a   Murasaki, Osamu ^b   Kaibara, Muneshige ^b   Ueta, Yoichi ^a   Shigematsu, Akio ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALFAXALONE; ANESTHETIC AGENT; BISINDOLYLMALEIMIDE; COMPLEMENTARY DNA; COMPLEMENTARY RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; PROTEIN KINASE C INHIBITOR; QUINUCLIDINYL BENZILATE; TRITIUM;

ANESTHESIA MECHANISM; ANIMAL CELL; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; XENOPUS LAEVIS;

EID: 0042848833     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000068985.78588.E1     Document Type: Article

References (26)

1. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 2000;21:1-56.
2. Holzbauer M. Physiological aspects of steroids with anaesthetic properties. Med Biol 1976;54:227-42.
3. Child KJ, Currie JP, Dis B, et al. The pharmacological properties in animals of CT1341: a new steroid anaesthetic agent. Br J Anaesth 1971;43:2-13.
4. Harrison NL, Simmonds MA. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res 1984;323:287-92.
5. Cottrell GA, Lambert JJ, Peters JA. Modulation of GABAA receptor activity by alphaxalone. Br J Pharmacol 1987;90:491-500.
6. Shiraishi M, Shibuya I, Minami K, et al. A neurosteroid anesthetic, alphaxalone, inhibits nicotinic acetylcholine receptors in cultured bovine adrenal chromaffin cells. Anesth Analg 2002;95:900-6.
7. Horishita T, Minami K, Yanagihara N, et al. Alphaxalone, a neurosteroid anesthetic, inhibits norepinephrine transporter function in cultured bovine adrenal medullary cells. Anesth Analg 2002;95:1661-6.
8. Fibiger HC, Damsma G, Day JC. Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. Adv Exp Med Biol 1991;295:399-414.
9. Durieux ME. Muscarinic signaling in the central nervous system: recent developments and anesthetic implications. Anesthesiology 1996;84:173-89.
10. Yaksh TL, Dirksen R, Harty GJ. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol 1985;117:81-8.
11. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996;10:69-99.
12. Durieux ME. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg 1995;81:57-62.
13. Minami K, Vanderah TW, Minami M, et al. Inhibitory effects of anesthetics and ethanol on muscarinic receptors expressed in Xenopus oocytes. Eur J Pharmacol 1997;339:237-44.
14. Minami K, Yanagihara N, Toyohira Y, et al. Isoflurane inhibits nicotinic acetylcholine receptor-mediated 22Na+ influx and muscarinic receptor-evoked cyclic GMP production in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol 1994;349:223-9.
15. Do SH, Kamatchi GL, Durieux ME. The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: the role of protein kinase C. Anesth Analg 2001;93:375-81.
16. Shiraishi M, Minami K, Uezono Y, et al. Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M1 receptors. J Pharmacol Exp Ther 2001;299:255-60.
17. Shiga Y, Minami K, Shiraishi M, et al. The inhibitory effects of tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M(3) receptors. Anesth Analg 2002;95:1269-73.
18. Harris RA, Mihic SJ, Dildy-Mayfield JE, et al. Actions of anesthetics on ligand-gated ion channels: role of receptor subunit composition. FASEB J 1995;9:1454-62.
19. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-81.
20. Sear JW, Prys-Roberts C. Plasma concentrations of alphaxalone during continuous infusion of Althesin. Br J Anaesth 1979;51:861-5.
21. Child KJ, Gibson W, Harnby G, et al. Metabolism and excretion of Althesin (CT 1341) in the rat. Postgrad Med J 1972;48:37-43.
22. Sumikawa K, Matsumoto T, Amenomori Y, et al. Selective actions of intravenous anesthetics on nicotinic- and muscarinic-receptor-mediated responses of the dog adrenal medulla. Anesthesiology 1983;59:412-6.
23. Schroter A, Trankle C, Mohr K. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts. Naunyn Schmiedebergs Arch Pharmacol 2000;362:512-9.
24. q protein function. Mol Pharmacol 2001;59:294-301.
25. Zucker J. Central cholinergic depression reduces MAC for isoflurane in rats. Anesth Analg 1991;72:790-5.
26. Eger EI II, Zang Y, Laster M, et al. Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics. Anesth Analg 2002;94:1500-4.